(GETI-B) Getinge ser. - Ratings and Ratios

Getinge AB (publ) is a global leader in medical equipment and solutions, specializing in operating rooms, intensive-care units, and sterilization departments. Founded in 1904 and headquartered in Gothenburg, Sweden, the company operates through three key segments: Acute Care Therapies, Life Science, and Surgical Workflows. Its product portfolio includes extracorporeal membrane oxygenation (ECMO), mechanical ventilation, advanced patient monitoring systems, and ICU infrastructure equipment. Getinge also provides solutions for cardiac surgery, including intra-aortic balloon counterpulsation and beating heart surgery equipment, as well as surgical perfusion and endoscopic vessel harvesting tools. Additionally, the company offers a wide range of sterilization and infection control solutions, including pre-cleaning, disinfection, and low-temperature sterilization technologies. Its products are distributed through a global network of sales companies, agents, and distributors across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region.

Getinge AB (publ) is listed on the Stockholm Stock Exchange under the ticker symbol GETI-B. The company operates in the Health Care Equipment industry and has a market capitalization of 55,944.79M SEK. Its current stock price is 194.15 SEK, with a 20-day average volume of 892,258 shares. The stocks short-term trend indicates a decline, as it is trading below its 20-day and 50-day simple moving averages (204.82 and 211.39, respectively). However, the 200-day SMA of 201.16 suggests a neutral long-term outlook. The average true range (ATR) of 6.83 indicates moderate volatility. From a fundamental perspective, the company has a price-to-earnings (P/E) ratio of 34.12, with a forward P/E of 17.12, signaling expectations of future earnings growth. The price-to-book (P/B) ratio of 1.79 and price-to-sales (P/S) ratio of 1.61 reflect its valuation relative to book value and revenue. The return on equity (RoE) of 4.96% highlights its profitability.